Together, our results along with the clinical and human pathology observations may suggest that the cytopathological stimuli in PLA2G6-associated neurodegeneration are different from those in sporadic PD, although they likely eventually converge on similar or identical pathways as neurodegeneration proceeds. The gene discussed is PLA2G6; the disease is Parkinson disease.